This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
NCCN clinical practice guidelines in oncology (NCCN Guidelines®). Esophageal and esophagogastric junction cancers, version 1. 2019. [cited 2019 Jan 15]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdfNCCN clinical practice guidelines in oncology (NCCN Guidelines®)Esophageal and esophagogastric junction cancers, version 12019[cited 2019 Jan 15]. Available athttps://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdfSearch in Google Scholar
Lordick F, Mariette C, Haustermans K, Obermannova R, Arnold D. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27(Suppl 5): v50-7. doi: 10.1093/ annonc/mdw329LordickFMarietteCHaustermansKObermannovaRArnoldDOesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol201627Suppl 5v50710.1093/annonc/mdw329Open DOISearch in Google Scholar
Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999; 281: 1623-7. doi: 10.1001/ jama.281.17.1623CooperJSGuoMDHerskovicAMacdonaldJSMartensonJAAl-SarrafMet alChemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology GroupJAMA19992811623710.1001/jama.281.17.1623Open DOISearch in Google Scholar
van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BPL, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-84. doi: 10.1056/NEJMoa1112088van HagenPHulshofMCCMvan LanschotJJBSteyerbergEWvan Berge HenegouwenMIWijnhovenBPLet alPreoperative chemoradiotherapy for esophageal or junctional cancerN Engl J Med201236620748410.1056/NEJMoa1112088Open DOISearch in Google Scholar
Jeene PM, van Laarhoven HWM, Hulshof MCCM. The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer. Best Pract Res Clin Gastroenterol 2018; 36-37: 53-9. doi: 10.1016/j.bpg.2018.11.011JeenePMvan LaarhovenHWMHulshofMCCMThe role of definitive chemoradiation in patients with non-metastatic oesophageal cancerBest Pract Res Clin Gastroenterol201836-3753910.1016/j.bpg.2018.11.011Open DOISearch in Google Scholar
Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 2015; 16: 1090-8. doi: 10.1016/S1470-2045(15)00040-6ShapiroJvan LanschotJJBHulshofMCCMvan HagenPvan BergeHenegouwen MIWijnhovenBPLet alNeoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialLancet Oncol2015161090810.1016/S1470-2045(15)00040-6Open DOISearch in Google Scholar
Czito BG, DeNittis AS, Palta M. Esophageal Cancer. In: Halperin EC, Wazer DE, Perez CA, Brady LW, editors. Principles and practice of radiation oncology 6th edition. Philadelphia: Lippincott Williams&Wilkins; 2013. p. 995-1023.CzitoBGDeNittisASPaltaMEsophageal CancerHalperinECWazerDEPerezCABradyLWPrinciples and practice of radiation oncology6th editionPhiladelphiaLippincott Williams&Wilkins20139951023Search in Google Scholar
Adebahr S, Schimek-Jasch T, Nestle U, Brunner TB. Oesophagus side effects related to the treatment of oesophageal cancer or radiotherapy of other thoracic malignancies. Best Pract Res Clin Gastroenterol 2016; 30: 565-80. doi: 10.1016/j.bpg.2016.07.003AdebahrSSchimek-JaschTNestleUBrunnerTBOesophagus side effects related to the treatment of oesophageal cancer or radiotherapy of other thoracic malignanciesBest Pract Res Clin Gastroenterol2016305658010.1016/j.bpg.2016.07.00327644905Open DOISearch in Google Scholar
Common Terminology Criteria for Adverse Events (CTCAE), version 4.0. [cited 2019 Jan 15]. Available at: https://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdfCommon Terminology Criteria for Adverse Events (CTCAE), version 4.0[cited 2019 Jan 15]. Available athttps://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdfSearch in Google Scholar
Guidelines for the treatment of esophageal and esophagogastric junction cancers. [Slovenian]. Anderluh F, But Hadžić J, Crnjac A, Gačevski G, Hlebanja Z, Jeromen A, et al, editors. [cited 2019 Jan 15]. Available at: https://www.onko-i.si/fileadmin/user_upload/Smernice_za_zdravljenje_raka_poziralnika_in_EGS_splet.pdfGuidelines for the treatment of esophageal and esophagogastric junction cancers. [Slovenian]AnderluhFBut HadžićJCrnjacAGačevskiGHlebanjaZJeromenAet al, editors[cited 2019 Jan 15]Available athttps://www.onko-i.si/fileadmin/user_upload/Smernice_za_zdravljenje_raka_poziralnika_in_EGS_splet.pdfSearch in Google Scholar
Haefner MF, Lang K, Verma V, Koerber SA, Uhlmann L, Debus J, et al. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer. Outcomes and patterns of failure. Strahlentherapie Oncol 2018; 194: 116-24. doi: 10.1007/s00066-017-1211-0HaefnerMFLangKVermaVKoerberSAUhlmannLDebusJet alNeoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer. Outcomes and patterns of failureStrahlentherapie Oncol20181941162410.1007/s00066-017-1211-028916906Open DOISearch in Google Scholar
Jordan T, Mastnak DM, Palamar N, Kozjek NR. Nutritional therapy for patients with esophageal cancer. Nutr Cancer 2018; 70: 23-9. doi: 10.1080/01635581.2017.1374417JordanTMastnakDMPalamarNKozjekNRNutritional therapy for patients with esophageal cancerNutr Cancer20187023910.1080/01635581.2017.137441729016197Open DOISearch in Google Scholar
Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9201. J Clin Oncol 2007; 25: 1160-8. doi: 10.1200/JCO.2005.04.7118BedenneLMichelPBoucheOMilanCMarietteCConroyTet alChemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9201J Clin Oncol2007251160810.1200/JCO.2005.04.711817401004Open DOISearch in Google Scholar
Tomasello G, Ghidini M, Barni S, Passalacqua R, Petrelli F. Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer. Expert Rev Clin Pharmacol 2017; 10: 649-60. doi: 10.1080/17512433.2017.1313112TomaselloGGhidiniMBarniSPassalacquaRPetrelliFOverview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancerExpert Rev Clin Pharmacol2017106496010.1080/17512433.2017.131311228349718Open DOISearch in Google Scholar
Luo Y, Mao Q, Wang X, Yu J, Li M. Radiotherapy for esophageal carcinoma: dose, response and survival. Cancer Manag Res 2017; 10: 13-21. doi: 10.2147/CMAR.S144687LuoYMaoQWangXYuJLiMRadiotherapy for esophageal carcinoma: dose, response and survivalCancer Manag Res201710132110.2147/CMAR.S144687Open DOISearch in Google Scholar
Li XA, Chibani O, Greenwald B, Suntharalingam M. Radiotherapy dose perturbation of metallic esophageal stents. Int J Radiat Oncol Biol Phys 2002; 54: 1276-85. doi: 10.1016/S0360-3016(02)03803-8LiXAChibaniOGreenwaldBSuntharalingamMRadiotherapy dose perturbation of metallic esophageal stentsInt J Radiat Oncol Biol Phys20025412768510.1016/S0360-3016(02)03803-8Open DOISearch in Google Scholar
Stahl M, Stuschke M, Lehkmann N, Meyer H-J, Walz MK, Seeber S, et.al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-7. doi: 10.1200/JCO.2005.00.034StahlMStuschkeMLehkmannNMeyerH-JWalzMKSeeberSet.alChemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagusJ Clin Oncol2005232310710.1200/JCO.2005.00.03415800321Open DOISearch in Google Scholar
Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74. doi: 10.1200/ JCO.2002.20.5.1167MinskyBDPajakTFGinsbergRJPisanskyTMMartensonJKomakiRet alINT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high dose versus standard-dose radiation therapyJ Clin Oncol20022011677410.1200/JCO.2002.20.5.116711870157Open DOISearch in Google Scholar
Versteijne F, van Laarhoven HWM, van Hooft JE, van OS RM, Geijsen ED, van Berge Henegouwen MI, et al. Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern. Dis Esophagus 2015; 28: 453-9. doi: 10.1111/dote.12215VersteijneFvan LaarhovenHWMvan HooftJEvan OSRMGeijsenEDvan BergeHenegouwen MIet alDefinitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence patternDis Esophagus201528453910.1111/dote.1221524725186Open DOISearch in Google Scholar
Teoh AYB, Chiu PWY, Yeung WK, Liu SYW, Wong SKH, Ng EKW. Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial. Ann Oncol 2013; 24: 165-71. doi: 10.1093/annonc/mds206TeohAYBChiuPWYYeungWKLiuSYWWongSKHNgEKWLong-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trialAnn Oncol2013241657110.1093/annonc/mds20622887465Open DOISearch in Google Scholar
Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg 2018; 41: 210-5. doi: 10.1016/j.asjsur.2016.10.005HuangFLYuSJEsophageal cancer: Risk factors, genetic association, and treatmentAsian J Surg201841210510.1016/j.asjsur.2016.10.00527986415Open DOISearch in Google Scholar
Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 2015; 21: 7933-43. doi: 10.3748/wjg.v21.i26.7933Domper ArnalMJFerrandez ArenasALanas ArbeloaAEsophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countriesWorld J Gastroenterol20152179334310.3748/wjg.v21.i26.7933449933726185366Open DOISearch in Google Scholar
